AGA SectionUlcerative Colitis Care Pathway
Section snippets
Acknowledgments
The authors were members of the AGA Ulcerative Colitis-Focused IBD Care Pathways Taskforce.
References (12)
Crohn's disease evaluation and treatment: clinical decision tool
Gastroenterology
(2014)- et al.
Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease
Clin Gastroenterol Hepatol
(2014) - et al.
Association between serum concentration of infliximab and efficacy in adult patients with ulcerative colitis
Gastroenterology
(2014) - et al.
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management
J Crohns Colitis
(2012) - et al.
Methotrexate in combination with infliximab is no more effective than infliximab alone in patients with Crohn's disease
Gastroenterology
(2014) - et al.
Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: a meta-analysis
Gastroenterology
(2006)
There are more references available in the full text version of this article.
Cited by (0)
Conflicts of interest The authors disclose no conflicts.
Reprint requests Address requests for reprints to: AGA National Office, 4930 Del Ray Avenue, Bethesda, Maryland 20814. e-mail: [email protected]; telephone: (301) 272-1188.
Copyright © 2015 AGA Institute. Published by Elsevier Inc. All rights reserved.